Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrografin Use in Small Bowel Obstruction Caused by Adherences
NCT00601809Phase 4Completed
- Sponsor
- Alma Mater Studiorum – Università di Bologna
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diatrizoate meglumine + diatrizoate sodium in small bowel obstruction (SBO), sponsored by Alma Mater Studiorum – Università di Bologna. Started Sep 2003; status: completed.
02
Drugs
diatrizoate meglumine + diatrizoate sodium
03
Conditions
small bowel obstruction (SBO)
Beyond the preview
Go deeper on NCT00601809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601809.